首页> 外文期刊>Canadian Journal of Infectious Diseases and Medical Microbiology: Journal Canadien des Maladies Infectieuses >Determinants of Mortality in Patients with Nosocomial Acinetobacter baumannii Bacteremia in Southwest China: A Five-Year Case-Control Study
【24h】

Determinants of Mortality in Patients with Nosocomial Acinetobacter baumannii Bacteremia in Southwest China: A Five-Year Case-Control Study

机译:西南地区鲍曼不动杆菌细菌血症患者死亡率的决定因素:五年病例对照研究

获取原文
       

摘要

Purpose. This study was aimed to identify the determinants of in-hospital mortality in Acinetobacter baumannii (A. baumannii) bacteremia and to assess impact of carbapenem resistance on mortality. Methods. A five-year case-control study was conducted from January 2011 to December 2015 in a tertiary teaching hospital with 3200 beds, Southwest China. Clinical outcomes and potential determinants of mortality in patients with nosocomial A. baumannii bacteremia and carbapenem-resistant A. baumannii (CRAB) bacteremia were evaluated using Cox and logistic regression analyses. Results. A total of 118 patients with nosocomial A. baumannii bacteremia were included. Seventy-one percent (84/118) of them had carbapenem-resistant A. baumannii (CRAB) bacteremia. The in-hospital mortality of nosocomial A. baumannii bacteremia was 21.2%, and the attributable in-hospital mortality rate due to CRAB was 21.5%. Significant difference of 30-day in-hospital mortality in the Kaplan–Meier curves was found between CRAB and CSAB groups (log-rank test, ). The Cox regression analysis showed that patients with CRAB bacteremia had 2.72 times higher risk for 30-day in-hospital mortality than did those with carbapenem-susceptible A. baumannii (CSAB) bacteremia (95% confidence intervals (CIs) 1.14–6.61, ). The logistic regression analysis reported that mechanical ventilation and respiratory tract as origin of bacteremia were independent predictors of mortality among patients with nosocomial A. baumannii bacteremia and CRAB bacteremia, while high APACHE II score on the day of bacteremia and multiple organ dysfunction syndromes (MODS) during hospitalization were independent predictors of mortality among patients with nosocomial A. baumannii bacteremia but not CRAB bacteremia. Conclusion. It was the severity of illness (high APACHE II score and MODS) not carbapenem resistance that highlighted the mortality of patients with nosocomial A. baumannii bacteremia. The impact of mechanical ventilation on mortality suggested that respiratory dysfunction might prime the poor outcome. Protection of respiratory function during the progression of nosocomial A. baumannii bacteremia should be given more importance. Early identification and intervention of patients with nosocomial A. baumannii bacteremia in critical ill conditions were advocated.
机译:目的。这项研究旨在确定鲍曼不动杆菌(A. baumannii)菌血症的院内死亡率的决定因素,并评估碳青霉烯耐药性对死亡率的影响。方法。从2011年1月至2015年12月,在中国西南部拥有3200张床位的三级教学医院进行了为期五年的病例对照研究。使用Cox和Logistic回归分析评估了医院内鲍曼不动杆菌菌血症和碳青霉烯耐药鲍曼不动杆菌(CRAB)菌血症患者的临床结局和死亡率的潜在决定因素。结果。总共包括118例院内鲍曼不动杆菌菌血症患者。其中有71%(84/118)患有耐碳青霉烯的鲍曼不动杆菌(CRAB)菌血症。医院内鲍曼不动杆菌菌血症的院内死亡率为21.2%,归因于CRAB的院内死亡率为21.5%。在CRAB组和CSAB组之间,Kaplan-Meier曲线的30天院内死亡率存在显着差异(对数秩检验,)。 Cox回归分析显示,CRAB菌血症的患者30天住院死亡率比碳青霉烯易感鲍曼不动杆菌(CSAB)菌血症的患者高2.72倍(95%置信区间(CI)1.14–6.61,) 。 Logistic回归分析报告说,机械通气和呼吸道是菌血症的起源,是医院内鲍曼不动杆菌菌血症和CRAB菌血症患者死亡率的独立预测因子,而菌血症当天的APACHE II评分高和多器官功能障碍综合征(MODS)住院期间是院内鲍曼不动杆菌菌血症而非CRAB菌血症患者死亡率的独立预测因子。结论。疾病的严重程度(高APACHE II评分和MODS)而不是碳青霉烯耐药性凸显了医院内鲍曼不动杆菌菌血症患者的死亡率。机械通气对死亡率的影响提示呼吸功能障碍可能会导致不良预后。在医院感染鲍曼不动杆菌菌血症过程中保护呼吸功能应给予更多重视。提倡对危重病患者的医院内鲍曼不动杆菌菌血症进行早期识别和干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号